List of works - David Mischoulon

A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women.

scientific article published on 14 April 2015

Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses

scientific article

Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome

scientific article

Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group

scientific article

Association between physician beliefs regarding assigned treatment and clinical response: re-analysis of data from the Hypericum Depression Trial Study Group

scientific article

Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder.

scientific article

Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants

scientific article

Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).

scientific article published on 23 September 2017

Effects of smartphone use with and without blue light at night in healthy adults: A randomized, double-blind, cross-over, placebo-controlled comparison

scientific article

Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant major depressive disorder: A three week double blind pilot study

scientific article published on 29 August 2015

Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo

scientific article

International Society for Nutritional Psychiatry Research consensus position statement: nutritional medicine in modern psychiatry.

scientific article published in October 2015

Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation.

scientific article published on 18 February 2016

L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.

scientific article

Low-dose transdermal testosterone augmentation therapy improves depression severity in women.

scientific article

Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study

scientific article

Nutritional medicine as mainstream in psychiatry.

scientific article published on 25 February 2015

Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry

scientific article

Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants

scientific article

Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study

scientific article

Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence

scientific article

The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists

scientific article

Treatment Outcome in Depressed Latinos Predicted by Concomitant Psychosislike Symptoms.

scientific article published on 9 September 2015

List of works by David Mischoulon

A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women.

Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses

Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome

Association between patient beliefs regarding assigned treatment and clinical response: reanalysis of data from the Hypericum Depression Trial Study Group

Association between physician beliefs regarding assigned treatment and clinical response: re-analysis of data from the Hypericum Depression Trial Study Group

Bioavailability of S-adenosyl methionine and impact on response in a randomized, double-blind, placebo-controlled trial in major depressive disorder.

Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants

Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).

Effects of smartphone use with and without blue light at night in healthy adults: A randomized, double-blind, cross-over, placebo-controlled comparison

Efficacy and safety of a form of cranial electrical stimulation (CES) as an add-on intervention for treatment-resistant major depressive disorder: A three week double blind pilot study

Hypericum extract in patients with MDD and reversed vegetative signs: re-analysis from data of a double-blind, randomized trial of hypericum extract, fluoxetine, and placebo

International Society for Nutritional Psychiatry Research consensus position statement: nutritional medicine in modern psychiatry.

Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation.

L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.

Low-dose transdermal testosterone augmentation therapy improves depression severity in women.

Near-Infrared Transcranial Radiation for Major Depressive Disorder: Proof of Concept Study

Nutritional medicine as mainstream in psychiatry.

Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry

Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants

Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study

Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence

The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists

Treatment Outcome in Depressed Latinos Predicted by Concomitant Psychosislike Symptoms.